Topas Therapeutics GmbH

📍 Hamburg, Germany🗓 Founded 2016👥 20 employees💰 Last funded Nov 2019
Biotechnology Research🌐 topas-therapeutics.com
Website LinkedIn
Topas Therapeutics is a clinical-stage biotechnology company transforming the field of immune tolerance with a novel antigen-specific and targeted nanoparticle technology. Our antigen-coupled nanoparticle platform harnesses the tolerogenic power of the liver to treat autoimmune diseases. Our proprietary Topas Particles Conjugates target liver sinusoidal endothelial cells, a specific type of antigen-presenting cells highly effective at inducing T cell tolerance. With a technology adjustable to a broad spectrum of disease-relevant antigens, we have established a growing and advanced clinical pipeline to induce systemic tolerance. To learn more visit https://topas-therapeutics.com/
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2016
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Belgium
2
Frequently asked questions
Who invested in Topas Therapeutics GmbH?
Topas Therapeutics GmbH has 2 investors on record on gritt.io, 2 mid-stage.
When did Topas Therapeutics GmbH last raise funding?
The most recent investment in Topas Therapeutics GmbH recorded on gritt.io was in November 2019.
When was Topas Therapeutics GmbH founded?
Topas Therapeutics GmbH was founded in 2016.
What industry is Topas Therapeutics GmbH in?
Topas Therapeutics GmbH operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Topas Therapeutics GmbH based?
Topas Therapeutics GmbH is headquartered in Hamburg, Germany.